LRRK2 and Parkinson disease: As previously described [9], base editors, especially ABE, are more efficient for base correction of leucine-rich kinase2 (LRRK2), the dominant gain-of-function mutation in Parkinson’s disease (PD), compared with HDR with no apparent indels or off-target editing [78].